-
1
-
-
0003537324
-
-
Cambridge: Harvard University Press
-
Healy D. The antidepressant era. Cambridge: Harvard University Press, 1997:155-69.
-
(1997)
The Antidepressant Era
, pp. 155-169
-
-
Healy, D.1
-
3
-
-
0042145926
-
5-Hydroxyindoles in human cerebrospinal fluids
-
Ashcroft GW, Sharman DF. 5-Hydroxyindoles in human cerebrospinal fluids. Nature 1960;186:1050-1.
-
(1960)
Nature
, vol.186
, pp. 1050-1051
-
-
Ashcroft, G.W.1
Sharman, D.F.2
-
4
-
-
0014013394
-
5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases
-
Ashcroft GW, Crawford TBB, Stanton JB, et al. 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet 1966;2:1049-52.
-
(1966)
Lancet
, vol.2
, pp. 1049-1052
-
-
Ashcroft, G.W.1
Crawford, T.B.B.2
Stanton, J.B.3
-
5
-
-
0015512754
-
Modified amine hypothesis for the aetiology of affective illness
-
Ashcroft GW, Eccleston D, Murry LG, et al. Modified amine hypothesis for the aetiology of affective illness. Lancet 1972;2:573-7.
-
(1972)
Lancet
, vol.2
, pp. 573-577
-
-
Ashcroft, G.W.1
Eccleston, D.2
Murry, L.G.3
-
6
-
-
0022589227
-
Therapeutic effects of serotonin uptake inhibitors in depression
-
Åsberg M, Eriksson B, Mårtensson B, et al. Therapeutic effects of serotonin uptake inhibitors in depression. J Clin Psychiatry 1986;47(suppl 4):23-35S.
-
(1986)
J Clin Psychiatry
, vol.47
, Issue.SUPPL. 4
-
-
Åsberg, M.1
Eriksson, B.2
Mårtensson, B.3
-
7
-
-
0004080718
-
-
New York: Penguin Books, especially ch 3
-
Kramer PD. Listening to prozac. New York: Penguin Books, 1993, especially ch 3.
-
(1993)
Listening to Prozac
-
-
Kramer, P.D.1
-
8
-
-
0012313471
-
Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression
-
Toronto: James Lorimer
-
Healy D. Let them eat Prozac: the unhealthy relationship between the pharmaceutical industry and depression. Toronto: James Lorimer, 2003.
-
(2003)
-
-
Healy, D.1
-
9
-
-
33746147950
-
The receptor enters psychiatry
-
Healy D, eds. London: Arnold
-
Ashcroft G. The receptor enters psychiatry. In: Healy D, eds. The psychopharmacologists [vol 3]. London: Arnold, 2000:194.
-
(2000)
The Psychopharmacologists
, vol.3
, pp. 194
-
-
Ashcroft, G.1
-
10
-
-
0023621532
-
The structure of psychopharmacological revolutions
-
Healy D. The structure of psychopharmacological revolutions. Psychiatr Dev 1987;4:349-76.
-
(1987)
Psychiatr Dev
, vol.4
, pp. 349-376
-
-
Healy, D.1
-
11
-
-
0346859858
-
Antidepressants: A triumph of marketing over science?
-
www.journals.apa.org/prevention/volume5/pre0050025c.htm (accessed 19 Jun)
-
Antonuccio DO, Burns DD, Danton WG. Antidepressants: a triumph of marketing over science? Prevention & Treatment. www.journals.apa.org/ prevention/volume5/pre0050025c.htm (accessed 19 Jun 2004).
-
(2004)
Prevention & Treatment
-
-
Antonuccio, D.O.1
Burns, D.D.2
Danton, W.G.3
-
12
-
-
33644587939
-
Biology of mood disorders
-
Schatzberg AF, Nemeroff CB, eds. [3rd ed]. Washington DC: American Psychiatric Publishing
-
Flores BH, Musselman DL, DeBattista C, et al. Biology of mood disorders. In: Schatzberg AF, Nemeroff CB, eds. Textbook of psychopharmacology [3rd ed]. Washington DC: American Psychiatric Publishing, 2004:718.
-
(2004)
Textbook of Psychopharmacology
, pp. 718
-
-
Flores, B.H.1
Musselman, D.L.2
DeBattista, C.3
-
13
-
-
0032091519
-
The neurobiology of depression
-
Nemeroff CB. The neurobiology of depression. Scientific American 1998;278:2-9.
-
(1998)
Scientific American
, vol.278
, pp. 2-9
-
-
Nemeroff, C.B.1
-
14
-
-
4244024333
-
Psychopharmacology and the government of the self
-
www.pharmapolitics.com (accessed 4 May)
-
Healy D. Psychopharmacology and the government of the self. www.pharmapolitics.com (accessed 4 May 2004).
-
(2004)
-
-
Healy, D.1
-
15
-
-
0034438369
-
Antidepressant efficacy
-
Smith DC. Antidepressant efficacy. Ethical HUm Sci Serv 2000;2/3:215-16.
-
(2000)
Ethical HUm Sci Serv
, vol.2-3
, pp. 215-216
-
-
Smith, D.C.1
-
16
-
-
0030846899
-
The antidepressant web: Marketing depression and making medicines work
-
Medawar C. The antidepressant web: marketing depression and making medicines work. Int J Risk Safety Med 1997;10:86-91.
-
(1997)
Int J Risk Safety Med
, vol.10
, pp. 86-91
-
-
Medawar, C.1
-
17
-
-
0012391647
-
The emperors new drugs: An analysis of antidepressant medication data submitted to the US Food and Drug Administration
-
www.journals.apa.org/prevention/volume5,pre0050023a.html (accessed 14 May)
-
Kirsch I, Moore TJ, Scoboria A, et al. The emperors new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration. Prevention and Treatment. www.journals.apa.org/ prevention/volume5,pre0050023a.html (accessed 14 May 2004).
-
(2004)
Prevention and Treatment
-
-
Kirsch, I.1
Moore, T.J.2
Scoboria, A.3
-
18
-
-
2942668205
-
Sertraline and the Cheshire cat in geriatric depression
-
Carroll BJ. Sertraline and the Cheshire cat in geriatric depression. Am J Psychiatry 2004;161:759.
-
(2004)
Am J Psychiatry
, vol.161
, pp. 759
-
-
Carroll, B.J.1
-
19
-
-
22344434679
-
Efficacy of antidepressants in adults
-
Kirsch I, Moncrieff J. Efficacy of antidepressants in adults. BMJ 2005;331:155-7.
-
(2005)
BMJ
, vol.331
, pp. 155-157
-
-
Kirsch, I.1
Moncrieff, J.2
-
20
-
-
0034682156
-
Uneasy alliance: Clinical investigators and the pharmaceutical industry
-
at 1541
-
Bodenheimer T. Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 2000;342:1539-44 at 1541.
-
(2000)
N Engl J Med
, vol.342
, pp. 1539-1544
-
-
Bodenheimer, T.1
-
21
-
-
1942468862
-
Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data
-
Whittington CJ, Kendall T, Fonagy P, et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004;363:1341-5.
-
(2004)
Lancet
, vol.363
, pp. 1341-1345
-
-
Whittington, C.J.1
Kendall, T.2
Fonagy, P.3
-
22
-
-
2942533077
-
The truth about the drug companies: How they deceive us and what to do about it
-
New York: Random House
-
Angell M. The truth about the drug companies: how they deceive us and what to do about it. New York: Random House, 2004:125.
-
(2004)
, pp. 125
-
-
Angell, M.1
-
23
-
-
33746134974
-
-
House of Commons Health Committee. London: The Stationery Office
-
House of Commons Health Committee. The influence of the pharmaceutical industry vol 1. London: The Stationery Office, 2005:100.
-
(2005)
The Influence of the Pharmaceutical Industry
, vol.1
, pp. 100
-
-
-
24
-
-
33746136228
-
Profitably inventing new diseases
-
Wolfe SM. Profitably inventing new diseases. Health Letter 2003;19:2-3.
-
(2003)
Health Letter
, vol.19
, pp. 2-3
-
-
Wolfe, S.M.1
-
25
-
-
33645334319
-
Selling sickness: How the world's biggest pharmaceutical companies are turning us all into patients
-
New York: Nation
-
Moynihan R, Cassels A. Selling sickness: how the world's biggest pharmaceutical companies are turning us all into patients. New York: Nation, 2005.
-
(2005)
-
-
Moynihan, R.1
Cassels, A.2
-
26
-
-
33746144583
-
SmithKlineBeecham's business plan guide
-
December 1 1997-May 31 (accessed 12 Sept 2005)
-
SmithKlineBeecham's business plan guide December 1 1997-May 31, 1998, http://abcnews.go.com/Health/story?id=311956&page-1 (accessed 12 Sept 2005).
-
(1998)
-
-
-
27
-
-
0035856026
-
Sponsorship, authorship, and accountability
-
Davidoff F, DeAngelis CD, Drazen JM, et al. Sponsorship, authorship, and accountability. N Engl J Med 2001;345:825-7.
-
(2001)
N Engl J Med
, vol.345
, pp. 825-827
-
-
Davidoff, F.1
DeAngelis, C.D.2
Drazen, J.M.3
-
28
-
-
0032527543
-
Honorary authors and ghost authors in peer reviewed medical journals
-
Flanagin A, Carey LA, Fontanarosa PB, et al. Honorary authors and ghost authors in peer reviewed medical journals. JAMA 1998;280:222-4.
-
(1998)
JAMA
, vol.280
, pp. 222-224
-
-
Flanagin, A.1
Carey, L.A.2
Fontanarosa, P.B.3
-
29
-
-
0038639897
-
Interface between authorship, industry and science in the domain of therapeutics
-
Healy D, Cattell D. Interface between authorship, industry and science in the domain of therapeutics. Br J Psychiatry 2003;183:22-7.
-
(2003)
Br J Psychiatry
, vol.183
, pp. 22-27
-
-
Healy, D.1
Cattell, D.2
-
30
-
-
28644438445
-
On the origin of great ideas: Science in the age of big pharma
-
McHenry L. On the origin of great ideas: science in the age of big pharma. Hastings Cent Rep 2005;35:17-19.
-
(2005)
Hastings Cent Rep
, vol.35
, pp. 17-19
-
-
McHenry, L.1
-
31
-
-
33746122436
-
-
House of Commons official report: col 1038. www.parliament.the-stationery-office.co.uk/pa/cm200506/cmhansrd/cm051208/ debtext/51208-18.htm (accessed 16 Feb) (Hansard)
-
Flynn P. House of Commons official report: col 1038. www.parliament.the-stationery-office.co.uk/pa/cm200506/cmhansrd/cm051208/ debtext/51208-18.htm (accessed 16 Feb 2006) (Hansard).
-
(2006)
-
-
Flynn, P.1
-
32
-
-
0025131019
-
Suicidal preoccupation during fluoxetine treatment
-
Teicher MH, Glod C, Cole JO. Suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990;147:1380-1.
-
(1990)
Am J Psychiatry
, vol.147
, pp. 1380-1381
-
-
Teicher, M.H.1
Glod, C.2
Cole, J.O.3
-
33
-
-
0025972957
-
Suicidal ideation related to fluoxetine treatment
-
Masand P, Gupata S, Dewan M. Suicidal ideation related to fluoxetine treatment. N Engl J Med 1991;324:420.
-
(1991)
N Engl J Med
, vol.324
, pp. 420
-
-
Masand, P.1
Gupata, S.2
Dewan, M.3
-
34
-
-
0027204855
-
Sertraline-induced akathisia
-
LaPorta L. Sertraline-induced akathisia. J Clin Psychopharmacology 1993;13:219-20.
-
(1993)
J Clin Psychopharmacology
, vol.13
, pp. 219-220
-
-
LaPorta, L.1
-
36
-
-
0004174053
-
Toxic psychiatry: Why therapy, empathy and love must replace the drugs, electroshock, and biochemical theories of the "new psychiatry"
-
New York: St Martin's Press
-
Breggin PR. Toxic psychiatry: why therapy, empathy and love must replace the drugs, electroshock, and biochemical theories of the "new psychiatry". New York: St Martin's Press, 1991:167.
-
(1991)
, pp. 167
-
-
Breggin, P.R.1
-
37
-
-
33746169615
-
Suicide and neuropsychiatric adverse effects of SSRI medications: Methodological issues
-
(accessed 16 Feb)
-
Maris RRM. Suicide and neuropsychiatric adverse effects of SSRI medications: methodological issues. http://www.oism.info/en/therapy/ theory/suicide_and_neruopsychiatric_adverse_effects_of_ssri.htm (accessed 16 Feb 2006).
-
(2006)
-
-
Maris, R.R.M.1
-
38
-
-
33746144214
-
-
www.fda.gov/bbs/topics/news/2004/NEW01124.html (accessed 13 May)
-
www.fda.gov/bbs/topics/news/2004/NEW01124.html (accessed 13 May 2005).
-
(2005)
-
-
-
39
-
-
33746147947
-
-
www.fda.gov/cder/drug/antidepressants/AntidepressantPHA.htm (accessed 13 May)
-
www.fda.gov/cder/drug/antidepressants/AntidepressantPHA.htm (accessed 13 May 2005).
-
(2005)
-
-
-
40
-
-
13844320384
-
Suicide, depression, and antidepressants
-
Cipriani A, Barbui C, Geddes JR. Suicide, depression, and antidepressants. BMJ 2005;330:373-4.
-
(2005)
BMJ
, vol.330
, pp. 373-374
-
-
Cipriani, A.1
Barbui, C.2
Geddes, J.R.3
-
41
-
-
19744382704
-
Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: Nested case control study
-
Martinez C, Riebrock S, Wise L, et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case control study. BMJ 2005;330:389-93.
-
(2005)
BMJ
, vol.330
, pp. 389-393
-
-
Martinez, C.1
Riebrock, S.2
Wise, L.3
-
42
-
-
0034033736
-
Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials
-
Kahn A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. Arch Gen Psychiatry 2000;57:311-17.
-
(2000)
Arch Gen Psychiatry
, vol.57
, pp. 311-317
-
-
Kahn, A.1
Warner, H.A.2
Brown, W.A.3
-
43
-
-
0038135174
-
Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: An analysis of FDA reports
-
Khan A, Khan S, Kolts R, et al. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: an analysis of FDA reports. Am J Psychiatry 2003;160:790-2.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 790-792
-
-
Khan, A.1
Khan, S.2
Kolts, R.3
-
44
-
-
14244266287
-
Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: Meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review
-
Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ 2005;330:385-8.
-
(2005)
BMJ
, vol.330
, pp. 385-388
-
-
Gunnell, D.1
Saperia, J.2
Ashby, D.3
-
45
-
-
19744383529
-
Association between suicide attempts and selective serotonin reuptake inhibitors: Systematic review of randomised controlled trials
-
Fergusson D, Doucette S, Glass KC, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ 2005;330:396-9.
-
(2005)
BMJ
, vol.330
, pp. 396-399
-
-
Fergusson, D.1
Doucette, S.2
Glass, K.C.3
-
46
-
-
27544512549
-
Suicide attempts in clinical trials with paroxetine randomised against placebo
-
Aursnes I, Tvete IF, Gaasemyr J, et al. Suicide attempts in clinical trials with paroxetine randomised against placebo. BMC Medicine 2005;3:14.
-
(2005)
BMC Medicine
, vol.3
, pp. 14
-
-
Aursnes, I.1
Tvete, I.F.2
Gaasemyr, J.3
-
47
-
-
0035050704
-
Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors
-
Nordeng H, Lindemann R, Perminov KV, et al. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr 2001;90:288-91.
-
(2001)
Acta Paediatr
, vol.90
, pp. 288-291
-
-
Nordeng, H.1
Lindemann, R.2
Perminov, K.V.3
-
48
-
-
13444252680
-
Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: A database analysis
-
Sanz EJ, De-las-Cuevas C, Kiuru A, et al. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005;365:482-7.
-
(2005)
Lancet
, vol.365
, pp. 482-487
-
-
Sanz, E.J.1
De-las-Cuevas, C.2
Kiuru, A.3
-
50
-
-
33746174734
-
-
American Psychiatric Association. [4th ed]. Washington, DC: APA
-
American Psychiatric Association. Diagnostic and statistical manual of mental disorders [4th ed]. Washington, DC: APA, 2000:192-9.
-
(2000)
Diagnostic and Statistical Manual of Mental Disorders
, pp. 192-199
-
-
-
52
-
-
27744573507
-
The antidepressant solution: A step by step guide to safely overcoming antidepressant withdrawal, dependence and "addiction"
-
New York: The Free Press
-
Glenmullen J. The antidepressant solution: a step by step guide to safely overcoming antidepressant withdrawal, dependence and "addiction". New York: The Free Press, 2005:190-1.
-
(2005)
, pp. 190-191
-
-
Glenmullen, J.1
|